Skip to main navigation
Skip to search
Skip to main content
University of Strathclyde Home
Help & FAQ
Home
Profiles
Research units
Research output
Projects
Datasets
Equipment
Student theses
Impacts
Prizes
Activities
Search by expertise, name or affiliation
The antibacterial drug MGB-BP3: from discovery to clinical trial
Colin J. Suckling
Pure And Applied Chemistry
Research output
:
Contribution to journal
›
Article
›
peer-review
139
Downloads (Pure)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The antibacterial drug MGB-BP3: from discovery to clinical trial'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Distamycin A
100%
Ligand
100%
Antiinfective Agent
100%
Congocidine
100%
Natural Product
100%
Bacterium
50%
Antibiotics
50%
X-Ray
50%
Drug
50%
Antibiotic Agent
50%
Biological Activity
50%
DNA
50%
Toxicity
50%
Base
50%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
100%
Netropsin
100%
Bacterium
50%
DNA
50%
Global Health
50%
Ligand Binding
50%
Antimicrobial Activity
50%
X-Ray Crystallography
50%
Biological Activity
50%